Does anchoring vaginal mesh increase the potential for correcting stress incontinence?

BMC Urology

Table 5 Patients’ preoperative and postoperative POP-Q status

	Control group I (historical controls: TVM) (N = 62)			p value	Unadjasted OR (95% CI)	Adjusted OR^a (95% CI)	Modified TVM group (N = 62)			p value	Unadjasted OR (95% CI)	Adjusted OR^a (95% CI)	Control group II (historical controls: anterior colporrhaphy) (N = 124)
	Pre-operative	Post-operative	Mean difference	p value	Unadjasted OR (95% CI)	Adjusted OR^a (95% CI)	Pre-operative	Post-operative	Mean difference	p value	Unadjasted OR (95% CI)	Adjusted OR^a (95% CI)	Pre-operative	Post-operative	Mean difference
Aa	−0.97 ± 0.6	−1.37 ± 0.55	−0.40 ± 0.61	< 0.001	4.55(2.38–9.09)	4.83 (2.26–10.31)0.6	− 0.55 ± 0.69	− 1.68 ± 0.74	− 1.13 ± 0.80	< 0.001	43.5(1.61–125)	142.9(28.57–500.0)	−0.97 ± 0.36	− 0.76 ± 0.69	0.21 ± 0.60
Ba	−0.42 ± 0.64	− 1.74 ± 1.0	−2.16 ± 1.04	0.50	1.12 (0.8–1.56)	1.17(0.71–1.52)	−0.53 ± 1.08	−1.76 ± 0.94	−2.3 ± 1.08	< 0.001	6.49(3.65–11.63)	5.95(3.27–10.87)	− 0.49 ± 0.75	− 0.94 ± 1.48	− 0.45 ± 1.17
C	−6.55 ± 1.16	−6.82 ± 0.85	−0.27 ± 0.6	0.70	0.90 (0.54–1.52)	1.20(0.66–2.16)	− 6.53 ± 0.82	− 6.76 ± 0.67	− 0.23 ± 0.58	< 0.001	23.81(3.34–166.67)	25.0(3.70–166.7)	− 6.74 ± 0.61	− 6.45 ± 0.83	0.29 ± 0.62
TVL	8.25 ± 0.67	7.9 ± 0.62	−0.35 ± 0.48	0.018	0.37(0.16–0.86)	0.41(0.16–0.99)	7.82 ± 0.42	7.66 ± 0.60	−0.16 ± 0.41	< 0.001	n.m.^b	n.m.^b	7.91 ± 0.29	7.91 ± 0.29	0.0 ± 0.0

All recruited patients presented for anterior compartment POP–Q II–III (pelvic organ prolapse) and genuine SUI (stress urinary incontinence). The modified transvaginal mesh (mTVM) group comprised patients who received a four–arm mesh that was fixed to the mid-urethra. Control groups I and II include historical controls who participated in TVM and anterior colporrhaphy without any Kelly–Stoeckel suture, respectively
OR, Odds ratio; 95% CI, 95% confidence interval,
Adjusted OR^a, All variables were adjusted for age, previous parity, postmenopausal stage, previous vaginal operations and chronic systemic diseases, POP–Q stage and urge symptoms. n.m.^b, not measurable

ISSN: 1471-2490